AXGN Axogen Inc

Price (delayed)

$6.27

Market cap

$274.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.5

Enterprise value

$324.39M

Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore ...

Highlights
The revenue has grown by 14% YoY and by 3% from the previous quarter
The company's EPS rose by 14% YoY
Axogen's quick ratio has decreased by 33% YoY but it has increased by 2.5% from the previous quarter
The equity has decreased by 4.5% YoY and by 2.6% QoQ
Axogen's gross margin has decreased by 2.1% YoY

Key stats

What are the main financial stats of AXGN
Market
Shares outstanding
43.7M
Market cap
$274.03M
Enterprise value
$324.39M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.91
Price to sales (P/S)
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.98
Earnings
Revenue
$163.73M
EBIT
-$16.13M
EBITDA
-$9.93M
Free cash flow
-$21.05M
Per share
EPS
-$0.5
Free cash flow per share
-$0.49
Book value per share
$2.16
Revenue per share
$3.79
TBVPS
$4.2
Balance sheet
Total assets
$186.52M
Total liabilities
$93.36M
Debt
$72.07M
Equity
$93.16M
Working capital
$55.73M
Liquidity
Debt to equity
0.77
Current ratio
3.43
Quick ratio
2.09
Net debt/EBITDA
-5.07
Margins
EBITDA margin
-6.1%
Gross margin
79.7%
Net margin
-13%
Operating margin
-11.4%
Efficiency
Return on assets
-11.1%
Return on equity
-22.2%
Return on invested capital
-8%
Return on capital employed
-9.9%
Return on sales
-9.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXGN stock price

How has the Axogen stock price performed over time
Intraday
2.62%
1 week
3.81%
1 month
-8.73%
1 year
-31.17%
YTD
-8.2%
QTD
-22.3%

Financial performance

How have Axogen's revenue and profit performed over time
Revenue
$163.73M
Gross profit
$130.54M
Operating income
-$18.68M
Net income
-$21.28M
Gross margin
79.7%
Net margin
-13%
AXGN's operating margin is up by 36% YoY and by 16% QoQ
Axogen's operating income has increased by 27% YoY and by 13% from the previous quarter
The company's net margin rose by 24% YoY and by 5% QoQ
The revenue has grown by 14% YoY and by 3% from the previous quarter

Growth

What is Axogen's growth rate over time

Valuation

What is Axogen stock price valuation
P/E
N/A
P/B
2.91
P/S
1.66
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.98
The company's EPS rose by 14% YoY
AXGN's P/B is 34% below its 5-year quarterly average of 4.4 and 12% below its last 4 quarters average of 3.3
The equity has decreased by 4.5% YoY and by 2.6% QoQ
AXGN's P/S is 60% below its 5-year quarterly average of 4.1 and 17% below its last 4 quarters average of 2.0
The revenue has grown by 14% YoY and by 3% from the previous quarter

Efficiency

How efficient is Axogen business performance
The company's return on sales rose by 41% YoY and by 17% QoQ
Axogen's return on invested capital has increased by 27% YoY and by 13% QoQ
The ROA has increased by 12% YoY
Axogen's ROE has increased by 9% YoY

Dividends

What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXGN.

Financial health

How did Axogen financials performed over time
The total assets is 100% higher than the total liabilities
Axogen's quick ratio has decreased by 33% YoY but it has increased by 2.5% from the previous quarter
AXGN's current ratio is up by 19% since the previous quarter but it is down by 18% year-on-year
The company's debt is 23% lower than its equity
The debt to equity has grown by 4.1% YoY
The equity has decreased by 4.5% YoY and by 2.6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.